{"transactions":[{"id":670940,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17881,"kind":"person","name":"Person Julie","position":1,"cik":"0001946505","reported_name":"Person Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:28:18.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":212389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the options vest on August 12, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":212389,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":212389},"source":{"system":"sec-edgar","filing":"0001946505-26-000009","document":"form4-09012026_090914.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000194650526000009/form4-09012026_090914.xml","form_type":"4"}},{"id":670939,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17881,"kind":"person","name":"Person Julie","position":1,"cik":"0001946505","reported_name":"Person Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief People Officer"}}],"security":"Common Stock","published_at":"2026-09-01T21:28:18.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":107611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent an inducement award granted pursuant to a restricted stock unit (\"RSU\") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027."}],"balance_after":107611,"source":{"system":"sec-edgar","filing":"0001946505-26-000009","document":"form4-09012026_090914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000194650526000009/form4-09012026_090914.xml","form_type":"4"}},{"id":670938,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17880,"kind":"person","name":"Kratz Erica","position":1,"cik":"0002148785","reported_name":"Kratz Erica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Reg. & Quality Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:26:38.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":199115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":199115,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":199115},"source":{"system":"sec-edgar","filing":"0002148785-26-000009","document":"form4-09012026_090933.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214878526000009/form4-09012026_090933.xml","form_type":"4"}},{"id":670937,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17880,"kind":"person","name":"Kratz Erica","position":1,"cik":"0002148785","reported_name":"Kratz Erica","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Reg. & Quality Officer"}}],"security":"Common Stock","published_at":"2026-09-01T21:26:38.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":100885,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent an inducement award granted pursuant to a restricted stock unit (\"RSU\") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027."}],"balance_after":100885,"source":{"system":"sec-edgar","filing":"0002148785-26-000009","document":"form4-09012026_090933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214878526000009/form4-09012026_090933.xml","form_type":"4"}},{"id":670936,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:24:33.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":116150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026."}],"balance_after":116150,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":116150},"source":{"system":"sec-edgar","filing":"0001997710-26-000004","document":"form4-09012026_090929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000199771026000004/form4-09012026_090929.xml","form_type":"4"}},{"id":670935,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-09-01T21:24:33.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":58850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction represents a grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027."}],"balance_after":380190,"source":{"system":"sec-edgar","filing":"0001997710-26-000004","document":"form4-09012026_090929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000199771026000004/form4-09012026_090929.xml","form_type":"4"}},{"id":671440,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:23:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":46460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option shall vest as to 1/48th of the total award monthly, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on October 1, 2026."}],"balance_after":46460,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":46460},"source":{"system":"sec-edgar","filing":"0002042910-26-000003","document":"form4-09012026_090904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000204291026000003/form4-09012026_090904.xml","form_type":"4"}},{"id":671439,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Finance & PAO"}}],"security":"Common Stock","published_at":"2026-09-01T21:23:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":23540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported transaction represents a grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock upon vesting and settlement. These RSUs shall vest in four substantially equal annual installments, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the first tranche vesting on September 15, 2027."}],"balance_after":143600,"source":{"system":"sec-edgar","filing":"0002042910-26-000003","document":"form4-09012026_090904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000204291026000003/form4-09012026_090904.xml","form_type":"4"}},{"id":670934,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17878,"kind":"person","name":"Abu-Absi Susan","position":1,"cik":"0002148701","reported_name":"Abu-Absi Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-01T21:21:45.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":265487,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest as follows: 25% of the options vest on August 10, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":265487,"derivative":{"exercise_price":7.43,"expiration_date":"2036-09-01","underlying":"Common Stock","underlying_shares":265487},"source":{"system":"sec-edgar","filing":"0002148701-26-000008","document":"form4-09012026_090941.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214870126000008/form4-09012026_090941.xml","form_type":"4"}},{"id":670933,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17878,"kind":"person","name":"Abu-Absi Susan","position":1,"cik":"0002148701","reported_name":"Abu-Absi Susan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-01T21:21:45.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":134513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities represent an inducement award granted pursuant to a restricted stock unit (\"RSU\") award agreement with the Issuer. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments, subject to the Reporting Person's continued service as of the relevant vesting date, with the first tranche scheduled to vest on September 15, 2027."}],"balance_after":134513,"source":{"system":"sec-edgar","filing":"0002148701-26-000008","document":"form4-09012026_090941.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000214870126000008/form4-09012026_090941.xml","form_type":"4"}},{"id":713162,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":28118,"kind":"person","name":"Bender Jeremy","position":1,"cik":"0001863107","reported_name":"Bender Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-08T20:11:50.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in three substantially equal annual installments beginning on July 7, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":7.03,"expiration_date":"2036-07-07","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001193125-26-298542","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863107/000119312526298542/ownership.xml","form_type":"4"}},{"id":713161,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":28118,"kind":"person","name":"Bender Jeremy","position":1,"cik":"0001863107","reported_name":"Bender Jeremy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T20:11:50.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001193125-26-298542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863107/000119312526298542/ownership.xml","form_type":"4"}},{"id":722011,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-01T20:35:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":14858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":232693,"source":{"system":"sec-edgar","filing":"0001193125-26-292685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526292685/ownership.xml","form_type":"4"}},{"id":735919,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-06-16T20:30:18.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":12824,"price":6.42,"value":82330.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":265354,"source":{"system":"sec-edgar","filing":"0001193125-26-272703","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526272703/ownership.xml","form_type":"4"}},{"id":737522,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:31:08.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.21,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-271171","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526271171/ownership.xml","form_type":"4"}},{"id":737521,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:31:08.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":36000,"source":{"system":"sec-edgar","filing":"0001193125-26-271171","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526271171/ownership.xml","form_type":"4"}},{"id":737520,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":30347,"kind":"person","name":"Srivastava Sapna","position":1,"cik":"0001569226","reported_name":"Srivastava Sapna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:30:50.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.21,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-271170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526271170/ownership.xml","form_type":"4"}},{"id":737519,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":30347,"kind":"person","name":"Srivastava Sapna","position":1,"cik":"0001569226","reported_name":"Srivastava Sapna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:30:50.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":38500,"source":{"system":"sec-edgar","filing":"0001193125-26-271170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526271170/ownership.xml","form_type":"4"}},{"id":738716,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:30:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.21,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-271168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000119312526271168/ownership.xml","form_type":"4"}},{"id":738715,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:30:33.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":194167,"source":{"system":"sec-edgar","filing":"0001193125-26-271168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000119312526271168/ownership.xml","form_type":"4"}},{"id":737837,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-15T20:30:20.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":6.21,"expiration_date":"2036-06-11","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-271165","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000119312526271165/ownership.xml","form_type":"4"}},{"id":737836,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-15T20:30:20.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 11, 2027 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":38500,"source":{"system":"sec-edgar","filing":"0001193125-26-271165","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000119312526271165/ownership.xml","form_type":"4"}},{"id":771408,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":35603,"kind":"person","name":"Holles Natalie C.","position":1,"cik":"0001580111","reported_name":"Holles Natalie C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-19T20:59:48.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":2169103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on April 30, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":2169103,"derivative":{"exercise_price":7.39,"expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":2169103},"source":{"system":"sec-edgar","filing":"0001580111-26-000009","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000158011126000009/ownership.xml","form_type":"4"}},{"id":771407,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":35603,"kind":"person","name":"Holles Natalie C.","position":1,"cik":"0001580111","reported_name":"Holles Natalie C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-19T20:59:48.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":553844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were acquired pursuant to a performance RSU (\"PRSU\") award as Inducement Awards. The PRSUs are subject to both time-based vesting and the achievement of a performance condition, both of which must be satisfied before the PRSUs will be deemed vested. The PRSUs shall vest in four substantially equal annual installments commencing on April 15, 2027, subject to Ms. Holles' continued service as of each such time-based vesting date and the satisfaction of the performance condition. The expiration date of the PRSUs is the earlier of (i) the sixth (6th) anniversary of the grant date and (ii) the date Ms. Holles no longer has a service relationship with the Issuer. Any such PRSUs that have not vested on or prior to such expiration date shall be forfeited for no consideration."}],"balance_after":1153962,"source":{"system":"sec-edgar","filing":"0001580111-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000158011126000009/ownership.xml","form_type":"4"}},{"id":771406,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":35603,"kind":"person","name":"Holles Natalie C.","position":1,"cik":"0001580111","reported_name":"Holles Natalie C.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-19T20:59:48.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":600118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award as Inducement Awards. Each RSU represents the right to receive one share of the Issuer's common stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":600118,"source":{"system":"sec-edgar","filing":"0001580111-26-000009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000158011126000009/ownership.xml","form_type":"4"}},{"id":784611,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":48315,"kind":"organization","name":"Matrix Capital Management Company, LP","position":1,"cik":"0001410830","reported_name":"Matrix Capital Management Company, LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48316,"kind":"person","name":"GOEL DAVID E.","position":2,"cik":"0001548144","reported_name":"GOEL DAVID E.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, par value $0.00001 per share (Common Stock)","published_at":"2026-05-11T20:16:00.000Z","date":"2026-05-07","kind":"sale","planned":false,"acquired":false,"shares":6922870,"price":5.64,"value":39044986.8,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The securities reported herein are held by Matrix Capital Management Master Fund, LP (the \"Matrix Fund\"). Matrix Capital Management Company, LP (the \"Investment Manager\"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel (\"Mr. Goel\", and together with the Investment Manager, the \"Reporting Persons\"), serves as the Managing General Partner of the Investment Manager."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950142-26-001346","document":"es260777872_4-matrix.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410830/000095014226001346/es260777872_4-matrix.xml","form_type":"4"}},{"id":807639,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-16T22:49:19.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":11738,"price":7.02,"value":82400.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":217835,"source":{"system":"sec-edgar","filing":"0001193125-26-159579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526159579/ownership.xml","form_type":"4"}},{"id":870962,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:06:58.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":112661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":112661,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":112661},"source":{"system":"sec-edgar","filing":"0001193125-26-088170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526088170/ownership.xml","form_type":"4"}},{"id":870961,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T21:06:58.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":62339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":229573,"source":{"system":"sec-edgar","filing":"0001193125-26-088170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526088170/ownership.xml","form_type":"4"}},{"id":865637,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:06:39.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":128755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":128755,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":128755},"source":{"system":"sec-edgar","filing":"0001193125-26-088168","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088168/ownership.xml","form_type":"4"}},{"id":865636,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T21:06:39.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":71245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":278178,"source":{"system":"sec-edgar","filing":"0001193125-26-088168","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088168/ownership.xml","form_type":"4"}},{"id":865635,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:05:55.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":112661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":112661,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":112661},"source":{"system":"sec-edgar","filing":"0001193125-26-088158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088158/ownership.xml","form_type":"4"}},{"id":865634,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:05:55.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":62339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":243736,"source":{"system":"sec-edgar","filing":"0001193125-26-088158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088158/ownership.xml","form_type":"4"}},{"id":865633,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:05:31.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":160944,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":160944,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":160944},"source":{"system":"sec-edgar","filing":"0001193125-26-088154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088154/ownership.xml","form_type":"4"}},{"id":865632,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:05:31.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":89056,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":321340,"source":{"system":"sec-edgar","filing":"0001193125-26-088154","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526088154/ownership.xml","form_type":"4"}},{"id":868935,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:05:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":80472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":80472,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":80472},"source":{"system":"sec-edgar","filing":"0001193125-26-088150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526088150/ownership.xml","form_type":"4"}},{"id":868934,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-03-03T21:05:14.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":44528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":120060,"source":{"system":"sec-edgar","filing":"0001193125-26-088150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526088150/ownership.xml","form_type":"4"}},{"id":868297,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:06:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":249000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":249000,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":249000},"source":{"system":"sec-edgar","filing":"0001193125-26-088162","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526088162/ownership.xml","form_type":"4"}},{"id":868296,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T16:06:13.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":166000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":575815,"source":{"system":"sec-edgar","filing":"0001193125-26-088162","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526088162/ownership.xml","form_type":"4"}},{"id":902395,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-18T00:48:18.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":12079,"price":5.05,"value":60998.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":167234,"source":{"system":"sec-edgar","filing":"0001193125-26-055499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526055499/ownership.xml","form_type":"4"}},{"id":900410,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:47:51.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":15890,"price":5.05,"value":80244.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181397,"source":{"system":"sec-edgar","filing":"0001193125-26-055497","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526055497/ownership.xml","form_type":"4"}},{"id":900409,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-18T00:47:30.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":20401,"price":5.06,"value":103229.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":232284,"source":{"system":"sec-edgar","filing":"0001193125-26-055496","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312526055496/ownership.xml","form_type":"4"}},{"id":901469,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-02-18T00:47:08.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":8549,"price":5.06,"value":43257.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":75532,"source":{"system":"sec-edgar","filing":"0001193125-26-055494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526055494/ownership.xml","form_type":"4"}},{"id":901284,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-17T19:46:39.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":47648,"price":5.06,"value":241098.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":409815,"source":{"system":"sec-edgar","filing":"0001193125-26-055487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526055487/ownership.xml","form_type":"4"}},{"id":935603,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2026-01-20T23:41:49.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":1581,"price":4.86,"value":7683.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":84081,"source":{"system":"sec-edgar","filing":"0001193125-26-016939","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312526016939/ownership.xml","form_type":"4"}},{"id":935499,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-20T18:41:13.000Z","date":"2026-01-20","kind":"sale","planned":false,"acquired":false,"shares":16928,"price":4.86,"value":82270.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":457463,"source":{"system":"sec-edgar","filing":"0001193125-26-016938","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312526016938/ownership.xml","form_type":"4"}},{"id":997553,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-17T22:56:18.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":17109,"price":5.42,"value":92730.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.42 to $5.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":252685,"source":{"system":"sec-edgar","filing":"0001193125-25-284878","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312525284878/ownership.xml","form_type":"4"}},{"id":1012146,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-10-29T21:05:55.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":896,"price":6.35,"value":5689.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":85662,"source":{"system":"sec-edgar","filing":"0001193125-25-256620","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000119312525256620/ownership.xml","form_type":"4"}},{"id":1012116,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-10-29T17:05:32.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":9049,"price":6.35,"value":57461.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":474391,"source":{"system":"sec-edgar","filing":"0001193125-25-256619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000119312525256619/ownership.xml","form_type":"4"}},{"id":1017457,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-10-16T21:44:01.000Z","date":"2025-10-16","kind":"sale","planned":false,"acquired":false,"shares":12169,"price":6.35,"value":77273.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":197287,"source":{"system":"sec-edgar","filing":"0001193125-25-241622","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000119312525241622/ownership.xml","form_type":"4"}},{"id":1064257,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":2319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.25,"expiration_date":"2030-03-16","underlying":"Common Stock","underlying_shares":2319},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064256,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.16,"expiration_date":"2029-02-06","underlying":"Common Stock","underlying_shares":1094},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064255,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":4744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2028-02-21","underlying":"Common Stock","underlying_shares":4744},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064254,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.21,"expiration_date":"2027-04-12","underlying":"Common Stock","underlying_shares":547},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064253,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2026-10-26","underlying":"Common Stock","underlying_shares":547},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064252,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.48,"expiration_date":"2026-04-11","underlying":"Common Stock","underlying_shares":1094},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064251,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":false,"shares":2554,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.07,"expiration_date":"2025-09-03","underlying":"Common Stock","underlying_shares":2554},"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064250,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":7722,"price":6.7,"value":51737.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":86558,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064249,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":2319,"price":4.25,"value":9855.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":94280,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064248,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1094,"price":3.16,"value":3457.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":91961,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064247,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":4744,"price":2.74,"value":12998.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":90867,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064246,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":547,"price":5.21,"value":2849.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":86123,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064245,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":547,"price":5.48,"value":2997.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":85576,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064244,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1094,"price":5.48,"value":5995.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":85029,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1064243,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-08-18T20:34:22.000Z","date":"2025-08-18","kind":"exercise","planned":false,"acquired":true,"shares":2554,"price":5.07,"value":12948.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 18, 2025, the Reporting Person exercised long held stock options to purchase 12,899 shares of the Issuer's common stock, 7,722 of which were sold to cover the exercise price of such options."}],"balance_after":83935,"source":{"system":"sec-edgar","filing":"0000950170-25-109767","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025109767/ownership.xml","form_type":"4"}},{"id":1106012,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":30347,"kind":"person","name":"Srivastava Sapna","position":1,"cik":"0001569226","reported_name":"Srivastava Sapna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:10:48.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":6.18,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000950170-25-087891","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025087891/ownership.xml","form_type":"4"}},{"id":1106011,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":30347,"kind":"person","name":"Srivastava Sapna","position":1,"cik":"0001569226","reported_name":"Srivastava Sapna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:10:48.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":23500,"source":{"system":"sec-edgar","filing":"0000950170-25-087891","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025087891/ownership.xml","form_type":"4"}},{"id":1106990,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:10:34.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":6.18,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000950170-25-087890","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000095017025087890/ownership.xml","form_type":"4"}},{"id":1106989,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:10:34.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":179167,"source":{"system":"sec-edgar","filing":"0000950170-25-087890","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000095017025087890/ownership.xml","form_type":"4"}},{"id":1106353,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:10:21.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":17000,"derivative":{"exercise_price":6.18,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0000950170-25-087889","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017025087889/ownership.xml","form_type":"4"}},{"id":1106352,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":38182,"kind":"person","name":"Mattessich Antony C.","position":1,"cik":"0001709900","reported_name":"Mattessich Antony C.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-18T20:10:21.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 17, 2026 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date."}],"balance_after":23500,"source":{"system":"sec-edgar","filing":"0000950170-25-087889","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709900/000095017025087889/ownership.xml","form_type":"4"}},{"id":1122483,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T20:05:33.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on May 13, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":250000,"derivative":{"exercise_price":6.16,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0000950170-25-081616","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025081616/ownership.xml","form_type":"4"}},{"id":1122482,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-04T20:05:33.000Z","date":"2025-06-02","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on June 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":206933,"source":{"system":"sec-edgar","filing":"0000950170-25-081616","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025081616/ownership.xml","form_type":"4"}},{"id":1123164,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":false,"shares":10948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.07,"expiration_date":"2025-06-02","underlying":"Common Stock","underlying_shares":10948},"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1123163,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":9948,"price":6.16,"value":61279.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."}],"balance_after":483440,"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1123162,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-06-04T16:05:21.000Z","date":"2025-06-02","kind":"exercise","planned":false,"acquired":true,"shares":10948,"price":5.07,"value":55506.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were acquired and/or withheld to cover the exercise price and resulting tax obligations, as applicable, in connection with a net (cashless) exercise of stock options. The stock options subject to the net exercise were to expire June 2, 2025. These transactions were completed subsequent to the execution of a Lock-Up Agreement and the shares received are subject to the provisions of that agreement."}],"balance_after":493388,"source":{"system":"sec-edgar","filing":"0000950170-25-081615","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025081615/ownership.xml","form_type":"4"}},{"id":1141287,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Warrants (right to buy)","published_at":"2025-05-20T21:43:51.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."}],"balance_after":5000,"derivative":{"exercise_price":4.9,"exercise_date":"2025-05-16","expiration_date":"2030-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000950170-25-075412","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000095017025075412/ownership.xml","form_type":"4"}},{"id":1141286,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37036,"kind":"person","name":"Johnson David Michael","position":1,"cik":"0001808098","reported_name":"Johnson David Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-20T21:43:51.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":4.9,"value":98000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 20,000 shares of the Issuer's common stock and a warrant to purchase 5,000 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."}],"balance_after":166167,"source":{"system":"sec-edgar","filing":"0000950170-25-075412","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808098/000095017025075412/ownership.xml","form_type":"4"}},{"id":1140115,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock Warrants  (right to buy)","published_at":"2025-05-20T21:34:24.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."}],"balance_after":12500,"derivative":{"exercise_price":4.9,"exercise_date":"2025-05-16","expiration_date":"2030-05-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-075403","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025075403/ownership.xml","form_type":"4"}},{"id":1140114,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-20T21:34:24.000Z","date":"2025-05-16","kind":"sale","planned":false,"acquired":false,"shares":1519,"price":5.15,"value":7822.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":56933,"source":{"system":"sec-edgar","filing":"0000950170-25-075403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025075403/ownership.xml","form_type":"4"}},{"id":1140113,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":37609,"kind":"person","name":"Gibney Anthony S","position":1,"cik":"0001750132","reported_name":"Gibney Anthony S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-05-20T21:34:24.000Z","date":"2025-05-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":4.9,"value":245000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 16, 2025, the Reporting Person purchased 50,000 shares of the Issuer's common stock and a warrant to purchase 12,500 shares of the Issuer's common stock at a purchase price of $4.90 in an underwritten public offering."}],"balance_after":58452,"source":{"system":"sec-edgar","filing":"0000950170-25-075403","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025075403/ownership.xml","form_type":"4"}},{"id":1171138,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-04-17T00:36:48.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":897,"price":5.49,"value":4924.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":81381,"source":{"system":"sec-edgar","filing":"0000950170-25-054954","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025054954/ownership.xml","form_type":"4"}},{"id":1171332,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-17T00:36:30.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":7162,"price":5.49,"value":39319.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.48 to $5.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179313,"source":{"system":"sec-edgar","filing":"0000950170-25-054953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025054953/ownership.xml","form_type":"4"}},{"id":1182739,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-02T20:02:51.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in three substantially equal annual installments beginning on March 31, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":29000,"derivative":{"exercise_price":5.86,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0000950170-25-049279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025049279/ownership.xml","form_type":"4"}},{"id":1182738,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":24045,"kind":"person","name":"Bitetti Teresa Marie","position":1,"cik":"0001977608","reported_name":"Bitetti Teresa Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:02:51.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in three substantially equal annual installments beginning on April 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":21000,"source":{"system":"sec-edgar","filing":"0000950170-25-049279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025049279/ownership.xml","form_type":"4"}},{"id":1263322,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-19T00:31:27.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":2151,"price":7.75,"value":16670.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":209456,"source":{"system":"sec-edgar","filing":"0000950170-25-022655","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025022655/ownership.xml","form_type":"4"}},{"id":1264400,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-19T00:31:01.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":1404,"price":7.75,"value":10881.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82278,"source":{"system":"sec-edgar","filing":"0000950170-25-022654","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025022654/ownership.xml","form_type":"4"}},{"id":1263323,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-19T00:30:46.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":2534,"price":7.75,"value":19638.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":269794,"source":{"system":"sec-edgar","filing":"0000950170-25-022653","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025022653/ownership.xml","form_type":"4"}},{"id":1264137,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-18T19:30:26.000Z","date":"2025-02-18","kind":"sale","planned":false,"acquired":false,"shares":20221,"price":7.7541,"value":156795.6561,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.75 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":482440,"source":{"system":"sec-edgar","filing":"0000950170-25-022651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025022651/ownership.xml","form_type":"4"}},{"id":1284004,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:52:07.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":59525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":59525,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":59525},"source":{"system":"sec-edgar","filing":"0000950170-25-013829","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025013829/ownership.xml","form_type":"4"}},{"id":1284003,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63177,"kind":"person","name":"Plavsic Mark","position":1,"cik":"0001868719","reported_name":"Plavsic Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:52:07.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":90475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":211607,"source":{"system":"sec-edgar","filing":"0000950170-25-013829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025013829/ownership.xml","form_type":"4"}},{"id":1284002,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:51:47.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":79365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":79365,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":79365},"source":{"system":"sec-edgar","filing":"0000950170-25-013828","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025013828/ownership.xml","form_type":"4"}},{"id":1284001,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":17879,"kind":"person","name":"Hopkins Janet Jill","position":1,"cik":"0001997710","reported_name":"Hopkins Janet Jill","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-04T22:51:47.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":120635,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":272328,"source":{"system":"sec-edgar","filing":"0000950170-25-013828","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501796/000095017025013828/ownership.xml","form_type":"4"}},{"id":1286015,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:51:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":59525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":59525,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":59525},"source":{"system":"sec-edgar","filing":"0000950170-25-013827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025013827/ownership.xml","form_type":"4"}},{"id":1286014,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T22:51:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":90475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":186475,"source":{"system":"sec-edgar","filing":"0000950170-25-013827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025013827/ownership.xml","form_type":"4"}},{"id":1285377,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:51:16.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":29760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":29760,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":29760},"source":{"system":"sec-edgar","filing":"0000950170-25-013825","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025013825/ownership.xml","form_type":"4"}},{"id":1285376,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-02-04T22:51:16.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":45240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":83682,"source":{"system":"sec-edgar","filing":"0000950170-25-013825","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025013825/ownership.xml","form_type":"4"}},{"id":1285222,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T17:52:24.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":255680,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":255680,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":255680},"source":{"system":"sec-edgar","filing":"0000950170-25-013830","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025013830/ownership.xml","form_type":"4"}},{"id":1285221,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":63384,"kind":"person","name":"de los Pinos Elisabet","position":1,"cik":"0001889633","reported_name":"de los Pinos Elisabet","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T17:52:24.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":194320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On November 7, 2023, the Reporting Person filed a Form 4 which incorrectly included an additional 3,649 shares in the amount of securities beneficially owned directly after the reported transaction and excluded 3,649 shares from the amount of securities beneficially owned indirectly after the reported transaction. The Reporting Person's holdings after the transactions reported on this Form 4 reflect this correction."}],"balance_after":502661,"source":{"system":"sec-edgar","filing":"0000950170-25-013830","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1889633/000095017025013830/ownership.xml","form_type":"4"}},{"id":1298936,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":18047,"kind":"person","name":"Elazzouzi Amy","position":1,"cik":"0002042910","reported_name":"Elazzouzi Amy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Common Stock","published_at":"2025-01-22T02:09:23.000Z","date":"2025-01-21","kind":"sale","planned":false,"acquired":false,"shares":1001,"price":7.6715,"value":7679.1715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38442,"source":{"system":"sec-edgar","filing":"0000950170-25-007494","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2042910/000095017025007494/ownership.xml","form_type":"4"}}],"next_cursor":"2025-01-22T02:09:23.000000Z,1298936"}